Possible Anticancer Effect of Bioactive Extract Isolated from Agrocybe Chaxingu on Human Bladder Cancer Cells

Jonathan Rockoff¹, Akhil Saji¹, Jonathan Kroop¹, Muhammad Choudhury¹ and Sensuke Konno^1,

¹Department of Urology, New York Medical College, Valhalla, NY 10595, USA

Cite this paper:
Jonathan Rockoff, Akhil Saji, Jonathan Kroop, Muhammad Choudhury and Sensuke Konno. Possible Anticancer Effect of Bioactive Extract Isolated from Agrocybe Chaxingu on Human Bladder Cancer Cells. Journal of Cancer Research and Treatment. 2023; 11(1):1-5. doi: 10.12691/jcrt-11-1-1

Abstract

To seek for a more effective way to treat bladder cancer with the poor outcomes, we have been working on natural products with anticancer activity for a decade. Recently, we came across the bioactive extract of Agrocybe chaxingu mushroom, CHX, which had been shown to have anticancer activity with few side/adverse effects. Accordingly, we then investigated if CHX might have anticancer effect on the relatively less aggressive human bladder cancer 5637 cells (grade 2) in vitro. Cells were treated with varying concentrations of CHX (0-500 μg/ml) for 72 h, and cell viability was determined by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) assay to assess anticancer effect. To explore the anticancer mechanism of CHX, we also examined induction of oxidative stress (OXS), cell cycle, and apoptosis. We first found a significant (~50%) cell viability reduction in 5637 cells with 350 μg/ml of CHX, indicating its anticancer effect. Lipid peroxidation (LPO) assay revealed the significantly (~2.2-fold) increased oxidative stress (OXS) level as well. CHX also led to a G₁ cell cycle arrest with a ~37% increase in G₁-phase cell number and a ~44% decrease in S-phase cell number, compared to those in controls. This was further confirmed by the up-regulation of two G₁-specific cell cycle regulators, p21^WAF1 and p27^Kip1, with CHX treatment. Consequently, 5637 cells were found to undergo apoptosis, indicated by the down-regulation of anti-apoptotic bcl-2 concomitant with the up-regulation of pro-apoptotic Bax with CHX. In conclusion, CHX has anticancer effect on human bladder cancer 5637 cells, significantly reducing their cell viability. This is presumably attributed to elevated OXS, a G₁ cell cycle arrest, and ultimate apoptosis. Therefore, it is plausible that CHX may offer an alternative therapeutic option for low-grade bladder cancer cases.

Keywords:
bladder cancer Agrocybe chaxingu anticancer oxidative stress cell cycle arrest apoptosis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics 2021. CA Cancer J Clin. 2021; 71: 7-33.
[2]	Pow-Sang JM, Seigne JD. Contemporary management of superficial bladder cancer. Cancer Control. 2000; 7: 335-339.
[3]	Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009; 374: 239-249.
[4]	Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Updates in the English edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol. 2018; 73: 560-569.
[5]	Lenis AT, Lec PM, Chamie K. Bladder cancer: a review. JAMA. 2020; 324: 1980-1991.
[6]	Kimura T, Ishikawa H, Kojima T et al. Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future. Jpn J Clin Oncol. 2020; 50: 1097-1107.
[7]	Alexandroff AB, Jackson AM, O’Donnell MA, James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet. 1999; 353: 1689-1694.
[8]	Lv G, Zhang Z, Pan H, Fan L. Effect of physical modification of mushroom (A. chaxingu) powders on their physical and chemical properties. Food Sci Technol Res. 2014; 20: 731-738.
[9]	Choi JH, Abe N, Kodani S et al. Osteoclast-forming suppressing components from the medicinal mushroom Agrocybe chaxingu huang (Agaricomycetideae). Int J Med Mushrooms. 2010; 12: 151-155.
[10]	Koshino H, Lee IK, Kim JP, Kim WG, Uzawa J, Yoo ID. Agrocybenine, novel class alkaloid from the Korean mushroom Agrocybe cylindracea. Tetrahedron Lett. 1996; 37: 4549-4550.
[11]	Lu GY, Zhang ZF, Pan HJ, Fan LF. Antioxidant activities of extracts from the physically modified fruiting bodies of Agrocybe cylindracea in vitro. Mycosystema. 2011; 30; 355-360.
[12]	Ngai PHK, Zhao Z, Ng TB. Agrocybin, an antifungal peptide from the edible mushroom Agrocybe cylindracea. Peptides. 2005; 26: 191-196.
[13]	Kiho T, Sobue S, Ukai S. Structural features and hypoglycemic activities of two polysaccharides from a hot-water extract of Agrocybe cylindracea. Carbohydr Res. 1994; 251: 81-87.
[14]	Pasquale V, Ducci G, Campion G et al. Profiling and targeting of energy and redox metabolism in grade 2 bladder cancer cells with different invasiveness properties. Cells. 2020; 9: 2669-2695.
[15]	Dargel R. Lipid peroxidation: a common pathogenetic mechanism? Exp Toxic Pathol. 1992; 44: 169-181.
[16]	Sherr CJ. The Pezcoller lecture: cancer cell cycles revised. Cancer Res. 2000; 60: 3689-3695.
[17]	Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999; 13: 1501-1512.
[18]	Yip KW, Reed JC. Bcl-2 family proteins and cancer. Oncogene. 2008; 27: 6398-6406.
[19]	Leung PY, Miyashita K, Young M, Tsao CS. Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res. 1993; 13: 475-480.
[20]	Han MH, Park C, Jin CY et al. Apoptosis induction of human bladder cancer cells by sanguinarine through reactive oxygen species-mediated up-regulation of early growth response gene-1. PLoS One. 2013; 8: e63425-63434.
[21]	Prosperini A, Juan-Garcia A, Font G, Ruiz MJ. Reactive oxygen species involvement in apoptosis and mitochondrial damage in Caco-2 cells induced by enniatins A, A1, B and B1. Toxicol Lett. 2013; 222: 36-44.
[22]	Shin HR, You BR, Park WH. PX-12-induced HeLa cell death is associated with oxidative stress and GSH depletion. Oncol Lett. 2013; 6: 1804-1810.
[23]	Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35: 495-516.
[24]	Lieberthal W, Levine JS. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol. 1996; 271: F477-488.
[25]	De Bruin EC, Medema JP. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev. 2008; 34: 737-749.